We are thrilled to announce that Institut national du cancer (INCa) will provide financial support to a unique industry-academic R&D partnership gathering together Apmonia Therapeutics, MEDyC unit (CNRS UMR7369, Université de Reims Champagne-Ardenne, Prof. Stephane Dedieu, PI) and Gustave Roussy Cancer Center (INSERM U981, Dr. Alexandra Leary).
As part of the “Cancer Biology and Basic Sciences” 2020 call for proposals, our ambitious project aims at opening new therapeutic perspectives for the treatment of ovarian cancer, one of the highest unmet medical needs in oncology.
more :
https://www.e-cancer.fr/Institut-national-du-cancer/Appels-a-projets/Appels-a-projets-resultats/PLBIO-2020
